Ruxolitinib in clinical practice for therapy of myelofibrosis: Single USA center experience following Food and Drug Administration approval

Holly Geyer; Keith Cannon; Emily Knight; Veena Fauble; John Camoriano; Robyn Emanuel; Raoul Tibes; Ruben Mesa

doi:10.3109/10428194.2013.789507

Ruxolitinib in clinical practice for therapy of myelofibrosis: Single USA center experience following Food and Drug Administration approval

Holly Geyer, Keith Cannon, Emily Knight, Veena Fauble, John Camoriano, Robyn Emanuel, Raoul Tibes, Ruben Mesa

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	195-197
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	55
Issue number	1
DOIs	https://doi.org/10.3109/10428194.2013.789507
State	Published - Jan 2014
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428194.2013.789507

Cite this

@article{98838b577e6f4bfeb723a76e70d650fd,

title = "Ruxolitinib in clinical practice for therapy of myelofibrosis: Single USA center experience following Food and Drug Administration approval",

author = "Holly Geyer and Keith Cannon and Emily Knight and Veena Fauble and John Camoriano and Robyn Emanuel and Raoul Tibes and Ruben Mesa",

year = "2014",

month = jan,

doi = "10.3109/10428194.2013.789507",

language = "English (US)",

volume = "55",

pages = "195--197",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "1",

}

TY - JOUR

T1 - Ruxolitinib in clinical practice for therapy of myelofibrosis

T2 - Single USA center experience following Food and Drug Administration approval

AU - Geyer, Holly

AU - Cannon, Keith

AU - Knight, Emily

AU - Fauble, Veena

AU - Camoriano, John

AU - Emanuel, Robyn

AU - Tibes, Raoul

AU - Mesa, Ruben

PY - 2014/1

Y1 - 2014/1

UR - http://www.scopus.com/inward/record.url?scp=84887954865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887954865&partnerID=8YFLogxK

U2 - 10.3109/10428194.2013.789507

DO - 10.3109/10428194.2013.789507

M3 - Letter

C2 - 23647081

AN - SCOPUS:84887954865

SN - 1042-8194

VL - 55

SP - 195

EP - 197

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 1

ER -

Ruxolitinib in clinical practice for therapy of myelofibrosis: Single USA center experience following Food and Drug Administration approval

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this